search
Back to results

The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes

Primary Purpose

Diabetes Mellitus, Type 2

Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Treated and educated by nurses specialized in diabetes.
Sponsored by
Medical Research Foundation, The Netherlands
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus, Type 2 focused on measuring Randomized controlled trial, Delegation, Professional, Nurses

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients with DM2 who were referred by GPs to the diabetes outpatient clinics

Exclusion Criteria:

  • macroalbuminuria
  • serum creatinine level > 135 mol/l,
  • Cockcroft < 50 ml/min
  • alanine aminotransferase (ALT) > 120 U/l
  • pregnant woman

Sites / Locations

  • Isala Clinics

Outcomes

Primary Outcome Measures

mean decrease in:
HbA1c
blood pressure
total cholesterol
LDL cholesterol
cholesterol/HDL-ratio
proportion of patients achieving ranges of:
glycaemic control
lipid profile

Secondary Outcome Measures

health related quality of life (HRQOL)
diabetes related symptoms
patients' satisfaction
health care consumption and costs

Full Information

First Posted
October 31, 2006
Last Updated
October 31, 2006
Sponsor
Medical Research Foundation, The Netherlands
Collaborators
Netherlands: Ministry of Health, Welfare and Sports, Langerhans Foundation, the Netherlands
search

1. Study Identification

Unique Protocol Identification Number
NCT00394875
Brief Title
The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes
Official Title
The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes in a Secondary Care Setting: a Randomized Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
October 2006
Overall Recruitment Status
Completed
Study Start Date
March 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
January 2005 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Medical Research Foundation, The Netherlands
Collaborators
Netherlands: Ministry of Health, Welfare and Sports, Langerhans Foundation, the Netherlands

4. Oversight

5. Study Description

Brief Summary
To determine whether the management of type 2 diabetes mellitus (DM2) can be transferred from an internist to a supervised nurse specialized in diabetes (NSD) with a comparable quality of clinical care, health care costs, health related quality of life (HRQOL), and patient satisfaction.
Detailed Description
Diabetes mellitus type 2 (DM2) is a chronic, progressive illness which causes considerable morbidity and premature mortality.1-2 The worldwide prevalence of DM2 is high and is increasing steadily, also in The Netherlands.3-4 The burden of DM2 on health care has also increased because of the intensified cardiovascular risk management being practiced to prevent macrovascular morbidity and mortality in these patients.5 In the treatment of DM2, tight guidelines are increasingly recommended for optimizing glycaemia, blood pressure and lipid profile.6 Therefore, the burden of treatment has increased and will further increase per patient as well as per population with DM2. In order to meet this problem, we tested, in the current study, the hypothesis that well defined routine aspects in diabetes care, previously handled only by medical doctors in secondary care setting, may be safely transferred to supervised nurses specialized in diabetes (NSD), including the prescription of medication, resulting in at least the same quality of clinical care, health care costs, health related quality of life (HRQOL), and patient satisfaction.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2
Keywords
Randomized controlled trial, Delegation, Professional, Nurses

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
81 (false)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
Treated and educated by nurses specialized in diabetes.
Primary Outcome Measure Information:
Title
mean decrease in:
Title
HbA1c
Title
blood pressure
Title
total cholesterol
Title
LDL cholesterol
Title
cholesterol/HDL-ratio
Title
proportion of patients achieving ranges of:
Title
glycaemic control
Title
lipid profile
Secondary Outcome Measure Information:
Title
health related quality of life (HRQOL)
Title
diabetes related symptoms
Title
patients' satisfaction
Title
health care consumption and costs

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients with DM2 who were referred by GPs to the diabetes outpatient clinics Exclusion Criteria: macroalbuminuria serum creatinine level > 135 mol/l, Cockcroft < 50 ml/min alanine aminotransferase (ALT) > 120 U/l pregnant woman
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sebastiaan T Houweling, PhD
Organizational Affiliation
2. Department of General Practice, University of Groningen, Groningen, The Netherlands
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Betty Meyboom-de Jong, PhD
Organizational Affiliation
Department of General Practice, University of Groningen, Groningen, The Netherlands
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Henk Bilo, PhD
Organizational Affiliation
3. Centre of Excellence, Isala Clinics, Zwolle, The Netherlands
Official's Role
Study Chair
Facility Information:
Facility Name
Isala Clinics
City
Zwolle
ZIP/Postal Code
8025 AB
Country
Netherlands

12. IPD Sharing Statement

Learn more about this trial

The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes

We'll reach out to this number within 24 hrs